7Baggers
 Published on: 2025-11-17 10:28:41  newser.com Mon, 17 Nov 2025 16:28:41 GMT
 (agio) movement as an input in quant signal sets  news.stocktradersdaily.com Sat, 15 Nov 2025 15:18:02 GMT
 Published on: 2025-11-14 14:27:10  newser.com Fri, 14 Nov 2025 20:27:10 GMT
 A preview of Agios Pharma’s sickle-cell study readout  statnews.com Thu, 13 Nov 2025 11:32:20 GMT
 Agios Pharmaceuticals Shows Rising Price Performance With Jump To 84 RS Rating  Investor's Business Daily Wed, 12 Nov 2025 08:00:00 GMT
 published on: 2025-11-06 02:36:02  newser.com Thu, 06 Nov 2025 08:36:02 GMT
 agios pharmaceuticals sees relative strength rating improve to 74  Investor's Business Daily Wed, 05 Nov 2025 08:00:00 GMT
 agios pharmaceuticals announces new data on mitapivat  MSN Wed, 05 Nov 2025 02:47:58 GMT
 agios pharmaceuticals announces new data on mitapivat  TipRanks Mon, 03 Nov 2025 14:39:55 GMT
 agios (agio) unveils promising mitapivat data at ash 2025  GuruFocus Mon, 03 Nov 2025 14:39:32 GMT
 Agios Pharmaceuticals Clears Technical Benchmark, Hitting 80-Plus RS Rating  Investor's Business Daily Mon, 03 Nov 2025 08:00:00 GMT
 what is hc wainwright's estimate for agio fy2025 earnings?  MarketBeat Mon, 03 Nov 2025 07:29:57 GMT
 published on: 2025-11-02 02:45:06  newser.com Sun, 02 Nov 2025 07:45:06 GMT
 rbc capital keeps their buy rating on agios pharma (agio)  The Globe and Mail Sat, 01 Nov 2025 11:14:00 GMT
 published on: 2025-11-01 04:26:21  newser.com Sat, 01 Nov 2025 09:26:21 GMT
 Agios Pharmaceuticals Q3 2025 Earnings Preview  MSN Fri, 31 Oct 2025 12:44:55 GMT
 agios pharmaceuticals (agio) reports q3 loss, beats revenue estimates  sharewise.com Fri, 31 Oct 2025 08:25:27 GMT
 Agios Pharmaceuticals’ Earnings Call: Growth and Challenges  TipRanks Fri, 31 Oct 2025 07:00:00 GMT
 AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues  Yahoo Finance Fri, 31 Oct 2025 07:00:00 GMT

Agios Pharmaceuticals, Inc
(NASDAQ:AGIO) 

AGIO stock logo

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...

Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends